Pulmonary function abnormalities in type I Gaucher disease. 1996

E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
Dept of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel.

The purpose of this study was to determine the prevalence of pulmonary function and radiographic abnormalities among patients with type I Gaucher's disease, and to analyse the relationship between the pulmonary involvement and genotype and clinical severity score. All patients attending the Gaucher clinic at the Shaare Zedek Medical Center, Jerusalem, Israel, during the years 1992-1993 were prospectively evaluated. Each patient had pulmonary function tests, chest radiography, clinical assessment in terms of degree of organ involvement, and genotype analysis. Of the 95 patients included in the study (mean +/- SD age 29 +/- 15 yrs), 68% had some pulmonary function abnormalities, most commonly a reduced FRC and transfer coefficient for carbon monoxide (Kco), found in 45% and in 42% of the patients respectively. Total lung capacity (TLC) was reduced in 22% of the patients and forced expiratory flows in approximately one third of the patients. Signs of airtrapping (elevated residual volume (RV) or RV/TLC) were seen in 18% of the patients. Males had a higher incidence of reduced expiratory flow than females, (forced expiratory volume in one second (FEV1) was reduced in 36% of males vs 5% of females). Chest radiographic abnormalities were found in 17% of the patients, although only 4% had severe changes. Patients with abnormal pulmonary function had a significantly higher severity score index than those with normal pulmonary function tests. There was no association between abnormal pulmonary function and genotype or age. In conclusion, abnormal pulmonary function is common among type I Gaucher patients. Pulmonary function tests show airways obstruction, with reduced expiratory flows, reduction in lung volumes and alveolar-capillary diffusion abnormality. The rate of progression and the clinical significance need to be determined.

UI MeSH Term Description Entries
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females

Related Publications

E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
June 1988, Journal of medical genetics,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
April 1985, Acta ophthalmologica,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
June 1999, American journal of hematology,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
June 2005, BMC medical genetics,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
June 2000, Journal of inherited metabolic disease,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
August 1994, Annals of internal medicine,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
March 1988, Metabolism: clinical and experimental,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
January 2006, Pediatric hematology and oncology,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
June 2001, Neuropediatrics,
E Kerem, and D Elstein, and A Abrahamov, and Y Bar Ziv, and I Hadas-Halpern, and E Melzer, and C Cahan, and D Branski, and A Zimran
April 1989, American journal of medical genetics,
Copied contents to your clipboard!